Syngen BiotechLtd Future Growth
Future criteria checks 1/6
Syngen BiotechLtd is forecast to grow earnings and revenue by 8.1% and 4.8% per annum respectively. EPS is expected to grow by 8.2% per annum. Return on equity is forecast to be 12.6% in 3 years.
Key information
8.1%
Earnings growth rate
8.2%
EPS growth rate
| Pharmaceuticals earnings growth | 36.3% |
| Revenue growth rate | 4.8% |
| Future return on equity | 12.6% |
| Analyst coverage | Low |
| Last updated | 29 Dec 2023 |
Recent future growth updates
No updates
Recent updates
Does Syngen BiotechLtd (GTSM:8279) Have A Healthy Balance Sheet?
Mar 25
Should Syngen Biotech Co., Ltd. (GTSM:8279) Be Part Of Your Dividend Portfolio?
Feb 25Did You Miss Syngen Biotech's (GTSM:8279) Impressive 104% Share Price Gain?
Feb 04Is Syngen Biotech Co., Ltd.'s (GTSM:8279) Latest Stock Performance Being Led By Its Strong Fundamentals?
Jan 14Syngen Biotech (GTSM:8279) Seems To Use Debt Quite Sensibly
Dec 16
Syngen Biotech's (GTSM:8279) Earnings Are Growing But Is There More To The Story?
Nov 25Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 2,024 | 324 | N/A | 659 | 1 |
| 12/31/2024 | 1,927 | 307 | N/A | 358 | 1 |
| 12/31/2023 | 1,837 | 275 | 321 | 415 | N/A |
| 9/30/2023 | 1,890 | 287 | 294 | 363 | N/A |
| 6/30/2023 | 1,961 | 308 | 287 | 370 | N/A |
| 3/31/2023 | 1,996 | 329 | -237 | 354 | N/A |
| 12/31/2022 | 1,931 | 321 | -307 | 277 | N/A |
| 9/30/2022 | 1,848 | 319 | -258 | 328 | N/A |
| 6/30/2022 | 1,655 | 296 | -294 | 279 | N/A |
| 3/31/2022 | 1,545 | 262 | 226 | 300 | N/A |
| 12/31/2021 | 1,471 | 238 | 275 | 336 | N/A |
| 9/30/2021 | 1,372 | 212 | 287 | 357 | N/A |
| 6/30/2021 | 1,363 | 203 | 77 | 251 | N/A |
| 3/31/2021 | 1,349 | 217 | 76 | 283 | N/A |
| 12/31/2020 | 1,311 | 216 | -53 | 220 | N/A |
| 9/30/2020 | 1,310 | 225 | -138 | 147 | N/A |
| 6/30/2020 | 1,317 | 211 | -18 | 172 | N/A |
| 3/31/2020 | 1,301 | 195 | -5 | 145 | N/A |
| 12/31/2019 | 1,297 | 189 | 148 | 255 | N/A |
| 9/30/2019 | 1,281 | 181 | 124 | 211 | N/A |
| 6/30/2019 | 1,242 | 184 | 84 | 171 | N/A |
| 3/31/2019 | 1,152 | 153 | 55 | 129 | N/A |
| 12/31/2018 | 1,080 | 134 | -27 | 67 | N/A |
| 9/30/2018 | 997 | 116 | -20 | 74 | N/A |
| 6/30/2018 | 959 | 126 | -30 | 89 | N/A |
| 3/31/2018 | 944 | 143 | 65 | 197 | N/A |
| 12/31/2017 | 956 | 149 | -133 | 161 | N/A |
| 9/30/2017 | 934 | 145 | N/A | 90 | N/A |
| 6/30/2017 | 872 | 117 | N/A | 86 | N/A |
| 3/31/2017 | 809 | 96 | N/A | 41 | N/A |
| 12/31/2016 | 769 | 90 | N/A | 47 | N/A |
| 9/30/2016 | 731 | 79 | N/A | 81 | N/A |
| 6/30/2016 | 673 | 68 | N/A | 67 | N/A |
| 3/31/2016 | 639 | 65 | N/A | 77 | N/A |
| 12/31/2015 | 644 | 67 | N/A | 95 | N/A |
| 9/30/2015 | 626 | 67 | N/A | 100 | N/A |
| 6/30/2015 | 626 | 59 | N/A | 77 | N/A |
| 3/31/2015 | 600 | 45 | N/A | 75 | N/A |
| 12/31/2014 | 556 | 35 | N/A | 49 | N/A |
| 9/30/2014 | 476 | 22 | N/A | 33 | N/A |
| 6/30/2014 | 395 | 9 | N/A | 18 | N/A |
| 3/31/2014 | 335 | 12 | N/A | 17 | N/A |
| 12/31/2013 | 275 | 15 | N/A | 16 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 8279's forecast earnings growth (8.1% per year) is above the savings rate (1%).
Earnings vs Market: 8279's earnings (8.1% per year) are forecast to grow slower than the TW market (19.7% per year).
High Growth Earnings: 8279's earnings are forecast to grow, but not significantly.
Revenue vs Market: 8279's revenue (4.8% per year) is forecast to grow slower than the TW market (10.6% per year).
High Growth Revenue: 8279's revenue (4.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 8279's Return on Equity is forecast to be low in 3 years time (12.6%).